EKF Signs Exclusive Licensing Agreement for Novel Kidney Markers

News   Aug 15, 2012

 
EKF Signs Exclusive Licensing Agreement for Novel Kidney Markers
 
 
 

RELATED ARTICLES

Pathway in Neurons may Contribute to Neurodegenerative Disease

News

Pathway has received attention as potential drug target.

READ MORE

WGS Identifies New Genetic Signature for Autism

News

An analysis of the complete genomes of 2,064 people reveals that multiple genetic variations could contribute to autism.

READ MORE

Aqueous Humor Could Help Direct Retinoblastoma Treatment

News

Study demonstrates that aqueous humor removed during chemotherapy treatment contains tumor DNA, which could be used for a surrogate 'liquid' biopsy.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE